Viral Inactivation

A Global Strategic Business Report

MCP15506

RESEARCH DASHBOARD

OCT 2025

RELEASE DATE

419

EXECUTIVE POOL

5850

PRICE

84

EXPERT INPUTS

42

COMPANIES

102

DATA TABLES

173

PAGES

6

EDITION

WHAT'S BEHIND OUR DATA?

140857226

DOMAIN TRANSCRIPTS

6080276

BRANDS TRACKED

1729341

FEATURED COMPANIES

22574

TOPICS COVERED

82719

MARKET SEGMENTS

91

KEY INDUSTRIES

1574

CURATION TEAM

4761909

DECISION MAKERS

EXECUTIVE ENGAGEMENTS BY TIER (2780)

126

CXO

162

VICE PRESIDENT

1190

DIRECTOR

921

MANAGER

381

MARKETING

REQUEST FULL-STACK INDEX Includes 350+ pages validated sources

QUESTIONNAIRE EXECUTIVES DATA ROOM

OUR EXPERT PANELS

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

INFLUENCER INVITEE

WHY PARTICIPATE?

Expertise to the Power of YOU!

Collaborative Insights - Expand your deep domain insights from participants at competitive companies worldwide while you share your own!
Global Acumen Alerts - Expand your intelligence on your areas of interest by enabling our “Email Alerts” feature drawing from other influencers’ project participation.
Enterprise-wide Project Discounts - Discounts start @ 10% and build up as more participants support our ongoing projects in your space.
Complimentary Copies - We highly recommend collaboration with your team to draw upon their geographical domain expertise. Our platform enables collaborative engagements with 10 peers. When you or any of your team members purchase the report, the entire team will receive complimentary copies with full stack access to our data and updates for one year.
Annual Digital Subscription to one of the business publications or $100 value gift card - No Purchase Required! The lead participant will receive the digital subscription

The Economist
MIT Technology Review
Harvard Business Review

Note - Offer is limited to one participant per company. Offer may be withdrawn at anytime without notice once our annual maximum participation of leading players is fulfilled. Offer by invitation only, to enterprise executives in from companies featured in the project ranked. If you’ve received our initation, you’re qualified! If not, you may check your eligibility by registering to join our Project Expert Panel. Typically you must be have a Marketing, Strategy, Product Management or Business Development, role as a CXO or VP or Director or Manager directly involved with the P&L of the products or services covered in the report. You must complete all modules in the Primary Research Data Simulator.

MARKETGLASS

BASIC

Annual Prepaid Subscription
Single-User
10,000 Data Room Credits/Month
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use MarketGlass^TM Data Templates For Your Own Enterprise Data to Build Bespoke Research Reports.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.

PREMIUM

Annual Prepaid Subscription
One Research Project With One Complimentary Update/Year
10-User License
10-User Peer-to-Peer Collaborative Features
200 Domain Expert Insights (With Name, Company, and Date)
50,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

ENTERPRISE

Annual Prepaid Subscription
Four Research Projects With One Complimentary Update/Year
25-User License
25-User Peer-to-Peer Collaborative Engagements
500 Domain Expert Insights (With Name, Company, and Date)
150,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

HIGHLIGHTS & REPORT INDEX

Global Viral Inactivation Market to Reach US$1.5 Billion by 2030

The global market for Viral Inactivation estimated at US$781.3 Million in the year 2024, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 11.6% over the analysis period 2024-2030. Kits & Reagents, one of the segments analyzed in the report, is expected to record a 11.5% CAGR and reach US$865.8 Million by the end of the analysis period. Growth in the Systems segment is estimated at 12.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$214.8 Million While China is Forecast to Grow at 11.1% CAGR

The Viral Inactivation market in the U.S. is estimated at US$214.8 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$234.5 Million by the year 2030 trailing a CAGR of 11.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.1% and 9.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.

Global Viral Inactivation Market - Key Trends & Drivers Summarized

Why Is Viral Inactivation Crucial for Biopharmaceutical Manufacturing?
Viral inactivation has become a cornerstone of biopharmaceutical production, ensuring that biologic drugs, including vaccines, monoclonal antibodies, and plasma-derived therapies, meet the highest safety standards. Regulatory agencies such as the FDA, EMA, and WHO have stringent guidelines mandating viral inactivation to prevent contamination and ensure patient safety. With the increasing reliance on biologics for the treatment of chronic diseases and autoimmune disorders, the demand for effective viral inactivation methods is soaring. Traditional methods such as solvent/detergent treatment, heat inactivation, and low pH inactivation continue to be widely used, while novel technologies, including UV-C irradiation and nanotechnology-based viral removal systems, are gaining traction to enhance the efficiency of bioprocessing workflows.

What Innovations Are Shaping the Future of Viral Inactivation?
Technological innovations are revolutionizing viral inactivation techniques, improving process efficiency and ensuring compliance with evolving regulatory requirements. High-throughput and automated viral inactivation platforms are reducing process variability and improving scalability in large-scale biopharmaceutical production. The integration of AI and machine learning into bioprocessing workflows is optimizing inactivation parameters, enhancing reproducibility, and minimizing the risk of batch failures. Single-use bioprocessing systems are further driving advancements in viral inactivation, providing flexibility and cost-effectiveness while reducing cross-contamination risks. Additionally, advancements in filtration and chromatography techniques are enabling more precise and efficient viral removal without compromising product yield and quality.

How Is the Biopharmaceutical Industry Driving Demand for Viral Inactivation?
The surge in monoclonal antibody and recombinant protein production has significantly boosted demand for viral inactivation solutions, as pharmaceutical companies seek to enhance product safety and accelerate regulatory approvals. The increasing development of cell and gene therapies is also reinforcing the need for advanced viral clearance and inactivation technologies to ensure the integrity of these highly sensitive therapies. Furthermore, the rise of contract development and manufacturing organizations (CDMOs) in biopharmaceutical production is increasing outsourcing of viral inactivation services, allowing biopharma firms to focus on drug development while ensuring stringent safety standards. With global vaccine development efforts intensifying, particularly in response to pandemics and emerging infectious diseases, viral inactivation remains a fundamental step in ensuring vaccine safety and efficacy.

The growth in the viral inactivation market is driven by several factors, including the expanding biologics pipeline, advancements in inactivation technologies, and increasing regulatory emphasis on biopharmaceutical safety. The adoption of single-use bioprocessing and automated viral clearance platforms is accelerating process efficiency while reducing contamination risks. Additionally, the rise of contract manufacturing is propelling demand for specialized viral inactivation services, creating new growth opportunities in the sector. The growing need for robust inactivation techniques in cell and gene therapy production is further fueling market expansion. As biopharmaceutical companies continue to invest in next-generation therapeutics, the demand for innovative and scalable viral inactivation solutions is expected to rise, ensuring sustained market growth.

SCOPE OF STUDY

The report analyzes the Viral Inactivation market by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products, Cellular and Gene Therapy); Product (Kits & Reagents, Systems, Services).

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World..

SELECT PLAYERS

Charles River Laboratories International, Inc.; Clean Cells Inc.; Danaher Corporation; Merck KgaA; Parker Hannifin Corporation; Rad Source Technologies, Inc.; Sartorius AG; SGS Group (SGS SA); Texcell, Inc.; V.I.P.S. SA; WuXi AppTec Group

AI INTEGRATIONS

We’re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy

How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind

Viral Inactivation – Global Key Competitors Percentage Market Share in 2025 (E)

Competitive Market Presence - Strong/Active/Niche/Trivial for 42 Players Worldwide in 2025 (E)

Global Economic Update

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Growing Demand for Safe Biologics Driving Need for Effective Viral Inactivation Strategies

Expanding Monoclonal Antibody Production Fueling Adoption of Advanced Viral Inactivation Technologies

Increasing Penetration of UV-C Irradiation and Gamma Irradiation in Viral Inactivation Protocols

Rising Biopharmaceutical Contract Manufacturing Trends Enhancing Demand for Viral Inactivation Services

Advancements in Chemical Inactivation Agents Improving Safety and Efficacy of Biologics

Increasing Investment in Plasma-Derived Therapies Necessitating Robust Viral Inactivation Techniques

Growth in Blood and Blood Product Safety Regulations Accelerating Viral Inactivation Method Adoption

Expansion of Cell & Gene Therapy Products Creating New Opportunities for Novel Viral Inactivation Solutions

Development of Next-Generation Nanotechnology-Based Viral Inactivation Methods Enhancing Market Growth

Increasing Role of Automation and AI in Viral Inactivation Protocol Optimization

Strategic Collaborations Between Biopharma Firms and Regulatory Bodies Promoting Market Expansion

4. GLOBAL MARKET PERSPECTIVE

World Recent Past, Current & Future Analysis for Viral Inactivation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Viral Inactivation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Viral Inactivation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Vaccines and Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Vaccines and Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Vaccines and Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Stem Cell Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Stem Cell Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Stem Cell Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Blood and Blood Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Blood and Blood Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Blood and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Tissue/ Tissue Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Tissue/ Tissue Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Tissue/ Tissue Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Cellular and Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Cellular and Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Cellular and Gene Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

World Viral Inactivation Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

UNITED STATES

Viral Inactivation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)

USA Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

USA Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

USA 15-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2015, 2025 & 2030

USA Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

USA Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

USA 15-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2015, 2025 & 2030

CANADA

Canada Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Canada Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Canada 15-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2015, 2025 & 2030

Canada Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Canada Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Canada 15-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2015, 2025 & 2030

JAPAN

Viral Inactivation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)

Japan Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Japan Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Japan 15-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2015, 2025 & 2030

Japan Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Japan Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Japan 15-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2015, 2025 & 2030

CHINA

Viral Inactivation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)

China Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

China Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

China 15-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2015, 2025 & 2030

China Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

China Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

China 15-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2015, 2025 & 2030

EUROPE

Viral Inactivation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)

Europe Recent Past, Current & Future Analysis for Viral Inactivation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

Europe Historic Review for Viral Inactivation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for Viral Inactivation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030

Europe Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Europe Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2015, 2025 & 2030

Europe Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Europe Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2015, 2025 & 2030

FRANCE

Viral Inactivation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)

France Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

France Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

France 15-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2015, 2025 & 2030

France Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

France Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

France 15-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2015, 2025 & 2030

GERMANY

Viral Inactivation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)

Germany Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Germany Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Germany 15-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2015, 2025 & 2030

Germany Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Germany Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Germany 15-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2015, 2025 & 2030

ITALY

Italy Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Italy Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Italy 15-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2015, 2025 & 2030

Italy Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Italy Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Italy 15-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2015, 2025 & 2030

UNITED KINGDOM

Viral Inactivation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)

UK Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UK Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

UK 15-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2015, 2025 & 2030

UK Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UK Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

UK 15-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2015, 2025 & 2030

REST OF EUROPE

Rest of Europe Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Rest of Europe 15-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2015, 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Rest of Europe 15-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2015, 2025 & 2030

ASIA-PACIFIC

Viral Inactivation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)

Asia-Pacific Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2015, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2015, 2025 & 2030

REST OF WORLD

Rest of World Recent Past, Current & Future Analysis for Viral Inactivation by Product - Kits & Reagents, Systems and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of World Historic Review for Viral Inactivation by Product - Kits & Reagents, Systems and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Rest of World 15-Year Perspective for Viral Inactivation by Product - Percentage Breakdown of Value Sales for Kits & Reagents, Systems and Services for the Years 2015, 2025 & 2030

Rest of World Recent Past, Current & Future Analysis for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of World Historic Review for Viral Inactivation by Application - Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR

Rest of World 15-Year Perspective for Viral Inactivation by Application - Percentage Breakdown of Value Sales for Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue/ Tissue Products and Cellular and Gene Therapy for the Years 2015, 2025 & 2030

COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)	% VALIDATED RESEARCH *
Charles River Laboratories International, Inc.	%
Croda International Plc (Croda Pharma)	%
Merck KGaA	%
V.I.P.S. SA	%

* Login to Participate & View Data Stacks

* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlass^TM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.

View All Companies...

PARTICIPATE NOW!

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]

DIFFERENTIATORS

Integrity Trust Transparency

Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .

What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).

WHAT SETS US APART

FULL STACK DATA ACCESS

Primary Research Cluster Data
Influencer Engagement Stats
Evidence of Primary Research
List of Companies Engaged
Hundreds of Pages of Research
Peer Collaborative Interactions
Enterprise Data Exchanges
MarketGlassTM Platform Insider
Geographic Pricing Dynamics
Competitive Shares by Country
Brand Curation & Insights
Domain Expert Pool

Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.

Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.

Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.

Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.

Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.

Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.

Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.

Scroll